174 related articles for article (PubMed ID: 38476374)
1. Efficacy and Safety Profile of Tuberculin Protein Purified Derivative Injection As Immunotherapy For the Treatment of Cutaneous and Anogenital Warts: A Review Article.
Achdiat PA; Suwarsa O; Hidayat YM; Shafiee MN; Dwiyana RF; Hindritiani R; Sutedja E; Pudjiati SR; Hilmanto D; Dhamayanti M; Parwati I; Maharani RH; Sutedja EK; Avriyanti E; Yunitasari
Immunotargets Ther; 2024; 13():123-150. PubMed ID: 38476374
[TBL] [Abstract][Full Text] [Related]
2. Intradermal injection of PPD as a novel approach of immunotherapy in anogenital warts in pregnant women.
Eassa BI; Abou-Bakr AA; El-Khalawany MA
Dermatol Ther; 2011; 24(1):137-43. PubMed ID: 21276168
[TBL] [Abstract][Full Text] [Related]
3. Comparative Study in Efficacy and Safety of Intralesional Injections of Vitamin D3, Measles Rubella (MR) Vaccine, and Purified Protein Derivative (PPD) in the Management of Cutaneous Warts.
Ahmed R; Bhadbhade SP; Noojibail B; Shetty SM; Varghese A
J Cutan Aesthet Surg; 2020; 13(4):326-332. PubMed ID: 33911414
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of intralesional tuberculin protein purified derivative (PPD) and intralesional measles, mumps, rubella (MMR) vaccine for multiple resistant warts.
Mohammed YF; Ibrahim HS; Elbarbary MA; Elsaie ML
J Cosmet Dermatol; 2021 Mar; 20(3):868-874. PubMed ID: 33118675
[TBL] [Abstract][Full Text] [Related]
5. Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
Gilson R; Nugent D; Bennett K; Doré CJ; Murray ML; Meadows J; Haddow LJ; Lacey C; Sandmann F; Jit M; Soldan K; Tetlow M; Caverly E; Nathan M; Copas AJ
Health Technol Assess; 2020 Sep; 24(47):1-86. PubMed ID: 32975189
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Intralesional Immunotherapy with Tuberculin Purified Protein Derivative among Cutaneous Wart Patients.
Shrestha SB; Bhusal M; Jwarchan J; Gautam S; Shrestha PR
J Nepal Health Res Counc; 2023 Jul; 20(4):881-885. PubMed ID: 37489671
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of intralesional immunotherapy for the treatment of warts: A review of the literature.
Aldahan AS; Mlacker S; Shah VV; Kamath P; Alsaidan M; Samarkandy S; Nouri K
Dermatol Ther; 2016 May; 29(3):197-207. PubMed ID: 26991521
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, randomized controlled trial to compare the effectiveness and safety of purified protein derivative of tuberculin antigen with
Chandra S; Sil A; Datta A; Pal S; Das NK
Indian J Dermatol Venereol Leprol; 2019; 85(4):355-366. PubMed ID: 31172979
[TBL] [Abstract][Full Text] [Related]
9. Measurement of serum glutathione peroxidase, catalase and superoxide dismutase concentration in patients with external anogenital warts before and after treatment with intralesional tuberculin purified protein derivative.
Nada HA; El-Shabrawy MM; Ibrahim SH; Azab M
Andrologia; 2020 Oct; 52(9):e13661. PubMed ID: 32478892
[TBL] [Abstract][Full Text] [Related]
10. Combined intralesional injection of tuberculin purified protein derivative plus cryotherapy versus each alone in the treatment of multiple common warts.
Ibrahim H; El Taieb M; Nada E; Kamal E; Hegazy E
Dermatol Ther; 2022 Apr; 35(4):e15350. PubMed ID: 35103366
[TBL] [Abstract][Full Text] [Related]
11. Intralesional Measles, Mumps, Rubella Vaccine versus Tuberculin Purified Protein Derivative Injections in the Treatment of Palmoplantar and Periungual Warts: A Double-Blind Randomized Controlled Trial.
Rutnin S; Namasondhi A; Pomsoong C; Kositkuljorn C; Anuntrangsee T; Thadanipon K
Dermatology; 2023; 239(1):109-115. PubMed ID: 36282051
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy in viral warts with intradermal
Podder I; Bhattacharya S; Mishra V; Sarkar TK; Chandra S; Sil A; Pal S; Kumar D; Saha A; Shome K; Bandyopadhyay D; Das NK
Indian J Dermatol Venereol Leprol; 2017; 83(3):411. PubMed ID: 27852999
[TBL] [Abstract][Full Text] [Related]
13. Intralesional Purified Protein Derivative of Tuberculin Versus Intralesional Mycobacterium W Vaccine in Treatment of Recalcitrant Extragenital Warts: A Randomized, Single-Blinded, Comparative Study.
Mohta A; Jain SK; Mehta RD; Arora A
Indian J Dermatol; 2022; 67(1):26-30. PubMed ID: 35656274
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-18 serum level before and after intralesional immunotherapy with tuberculin purified protein derivative in patients with cutaneous and genital warts.
Korsa HHA; Nashaat HH; Halim HM; Atwa MA; Mahmoud Marie RE
J Cosmet Dermatol; 2022 Dec; 21(12):7035-7042. PubMed ID: 36059258
[TBL] [Abstract][Full Text] [Related]
15. Intralesional immunotherapy for pediatric warts: A review.
Fields JR; Saikaly SK; Schoch JJ
Pediatr Dermatol; 2020 Mar; 37(2):265-271. PubMed ID: 31930595
[TBL] [Abstract][Full Text] [Related]
16. Success of Intralesional Purified Protein Derivative Immunotherapy in the Treatment of Anogenital Warts: A Case Report.
Achdiat PA; Antariksa NC; Rowawi R; Suwarsa O; Hidayat YM; Dwiyana RF; Gunawan H; Hindritiani R
J Exp Pharmacol; 2022; 14():131-135. PubMed ID: 35401016
[TBL] [Abstract][Full Text] [Related]
17. Intralesional immunotherapy with tuberculin purified protein derivative (PPD) in recalcitrant wart: A randomized, placebo-controlled, double-blind clinical trial including an extra group of candidates for cryotherapy.
Amirnia M; Khodaeiani E; Fouladi DF; Masoudnia S
J Dermatolog Treat; 2016; 27(2):173-8. PubMed ID: 26295565
[TBL] [Abstract][Full Text] [Related]
18. Intralesional bivalent and quadrivalent human papillomavirus vaccines didn't significantly enhance the response of multiple anogenital warts when co-administered with intralesional Candida antigen immunotherapy. A randomized controlled trial.
Fawzy M; Nofal E; Abdelkhalek N; Ehab R
Arch Dermatol Res; 2023 Dec; 315(10):2813-2823. PubMed ID: 37573268
[TBL] [Abstract][Full Text] [Related]
19. Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study.
Shaheen MA; Salem SA; Fouad DA; El-Fatah AA
Dermatol Ther; 2015; 28(4):194-200. PubMed ID: 25847793
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of intralesional injection of vitamin D
Elsayed Ghaly N; El-Ashmawy AA; Abou Zeid M; E Shaker ES
J Cosmet Dermatol; 2021 Apr; 20(4):1231-1240. PubMed ID: 32892493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
